The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
![](https://webarchive.library.unt.edu/web/20121010210959im_/http://www.cancer.gov/images/spacer.gif)
acitretin
An orally-active metabolite of the synthetic aromatic retinoic acid agent etretinate with potential antineoplastic, chemopreventive, anti-psoratic, and embryotoxic properties. Acitretin activates nuclear retinoic acid receptors (RAR), resulting in induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells. This agent may also inhibit tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20121010210959im_/http://www.cancer.gov/images/spacer.gif)
Synonym: | ![]() | Trimethylmethoxyphenyl-retinoic acid | |
![]() | |||
US brand names: | ![]() | Etretin Soriatane | |
![]() | |||
Foreign brand name: | ![]() | Neotigason | |
![]() | |||
Code names: | ![]() | Ro 10-1670 Ro-10-1670 | |
![]() | |||
Chemical structure: | ![]() | (All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid | |
![]() |